Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Acura Pharmaceuticals, Inc. (ACUR)

-NasdaqCM

2.37 Up 0.01(0.42%) May 24, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 4   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit 4   -   -   -  
Operating Expenses
Research Development2,026  1,208  696  919  
Selling General and Administrative2,222  1,849  1,453  1,270  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (4,244) (3,057) (2,149) (2,189)
Income from Continuing Operations
Total Other Income/Expenses Net26   -   -  10  
Earnings Before Interest And Taxes(4,218)(3,016)(2,140)(2,179)
Interest Expense -   -   -   -  
Income Before Tax(4,218)(3,016)(2,140)(2,179)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(4,218)(3,016)(2,140)(2,179)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (4,218) (3,016) (2,140) (2,179)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (4,218) (3,016) (2,140) (2,179)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.